Oxerutins: Uses, Side Effects, Dosage - Drugvu

ℹ️ Compiled from public regulatory records · Last regulator revision: April 10, 2026🚩 Report this page

Oxerutins

Active ingredient

GB MHRA

Drug class: -
Availability: See label
Markets covered: 1
Products on record: 1

Overview

Oxerutins is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.

Regulatory status by market

Market	Regulator	Products	Last revision
GB United Kingdom	MHRA	1	April 10, 2026

GBUnited Kingdom· MHRA

1 product

Uses

GBOfficial regulatory label· revised April 10, 2026[1]

Relief of symptoms of oedema associated with chronic venous insufficiency.

How to take

GBOfficial regulatory label

Sources & citations

[1]MHRA (UK) · PL002400550 · revised April 10, 2026

Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.

Side effects & warnings

GBOfficial regulatory label· Adverse reactions· revised April 10, 2026[1]

Paroven may cause in rare cases gastrointestinal side effects or skin reactions like gastrointestinal disorder, flatulence, diarrhea, abdominal pain, stomach discomfort, dyspepsia, rash, pruritus or urticaria. Very rare is the occurrence of dizziness, headache, flushing, fatigue or hypersensitivity reactions like anaphylactoid reactions.
Adverse reactions are listed below by system organ class and frequency. Frequencies are defined as: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), or not known (can not to be estimated from available data).
Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. System Organ Class (SOC) Adverse Reaction Frequency Immune system disorders Very rare Anaphylactoid reactions Hypersensitivity reactions Nervous system disorders Very rare Dizziness Very rare Headache Vascular disorders Very rare Flushing Gastro-intestinal disorders Rare Gastrointestinal disorder, Rare Flatulence Rare Diarrhea Rare Abdominal pain Rare Stomach discomfort Dyspepsia Skin and subcutaneous tissue disorders Rare Rash Rare Pruritus Rare Urticaria Very Rare Photosensitivity Very Rare Alopecia General disorders and administration site conditions Very rare Fatigue Musculoskeletal, connective tissue and bone disorders Very Rare Arthralgia Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medical product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

GBOfficial regulatory label· Warnings and precautions· revised April 10, 2026[1]

Patients with heart, renal or hepatic impairment Treatment of leg oedema due to cardiac, renal or hepatic disease should be directed to the underlying cause; Paroven should not be used in these conditions. If leg pain and swelling do not improve, or get worse, the patient should consult their doctor.

This is not medical advice. Consult a qualified healthcare professional.